GOSS CIK: 1728117

Gossamer Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−189
FY22:
−187
FY23:
−159
FY24:
−3.47
FY25:
−171
Change from FY21 to FY25
millions USD
FY21:
−117
FY22:
−1.04
FY23:
−111
FY24:
29.0
FY25:
156
Change from FY21 to FY25
millions USD
FY21:
3.33
FY22:
117
FY23:
190
FY24:
−11.5
FY25:
6.43
millions USD
FY21:
−303
FY22:
−71.5
FY23:
−79.9
FY24:
14.0
FY25:
−8.34
(positive)
Change from FY21 to FY25
millions USD
FY21:
−190
FY22:
−187
FY23:
−159
FY24:
−3.47
FY25:
−171

All amounts in millions USD Data source:SEC EDGAR